When these patients are treated with leptin replacement therapy, appetite is suppressed, energy expenditure is stimulated, weight loss occurs, and insulin resistance, blood glucose levels, and dyslipidemia are reduced (Farooqi et al., 1999, 2000; Licinio et al., 2004). The gene discussed is LEP; the disease is metabolic syndrome.